Evaluation of the safety and effectiveness of oral propranolol in patients with von Hippel-Lindau disease and retinal hemangioblastomas: phase III clinical trial

BACKGROUND: von Hippel-Lindau disease (VHL) is a multisystem cancer syndrome caused by mutations in the VHL gene. Retinal hemangioblastoma is one of the most common tumours, and when it appears near the optic nerve, its treatment is challenging and risky. To date, no treatment has proven effective i...

詳細記述

保存先:
書誌詳細
出版年:BMJ Open Ophthalmol
主要な著者: González-Rodríguez, Beatriz, Villar Gómez de las Heras, Karina, Aguirre, Daniel T, Rodríguez-Padial, Luis, Albiñana, Virginia, Recio-Poveda, Lucía, Cuesta, Angel M, Botella, Luisa Mª, Jiménez-Escribano, Rosa María
フォーマット: Artigo
言語:Inglês
出版事項: BMJ Publishing Group 2019
主題:
Original Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6557078/
https://ncbi.nlm.nih.gov/pubmed/31245608
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjophth-2018-000203
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料